Additionally, doubling injection frequency increases the number of injection sites and potential for injection-related irritation, bruising, or lipodystrophy (changes in fat distribution under the skin)
Off-label Use Femara, besides its use, is often explored for off-label purposes
Common gastrointestinal complaints like nausea and vomiting are typical early with GLP-1 agonists, often diminishing over weeks with dose titration and regular monitoring
The treatment is indicated for glycemic control and to reduce the risk of hospitalization for heart failure for those with Type 2 diabetes who also have established cardiovascular disease or multiple cardiovascular risk factors
Scientists found that the venom of the Gila monster, a lizard that spends most of its time underground and only eats three to four times a year, had a hormone remarkably similar to human GLP-1 that didnt break down as quickly